01 4CUBIST PHARMS LLC
01 410420841
01 4Blank
01 4Blank
01 42034-03-14
Patent Expiration Date : 2034-03-14
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US Patent Number : 10420841
Drug Substance Claim :
Drug Product Claim :
Application Number : 206829
Patent Use Code : U-1672
Delist Requested :
Patent Use Description : TREATMENT OF COMPLICAT...
Patent Expiration Date : 2034-03-14
Patent Expiration Date : 2034-03-14
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US Patent Number : 10420841
Drug Substance Claim :
Drug Product Claim :
Application Number : 206829
Patent Use Code : U-2631
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
Patent Expiration Date : 2034-03-14
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US Patent Number : 10420841
Drug Substance Claim :
Drug Product Claim :
Application Number : 206829
Patent Use Code : U-3360
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
Patent Expiration Date : 2034-03-14
CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US Patent Number : 10420841
Drug Substance Claim :
Drug Product Claim :
Application Number : 206829
Patent Use Code : U-3361
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-03-14
